Genmab A/S (DE:GE9)

XETRA:GE9

GE9

Genmab A/S

RESEARCH TOOLSreports

Compare Genmab A/S (GE9) vs. Competitors

14 Followers

Comparison Results

GE9

Genmab A/S

€240.40

€14.86B

126.08

45.66%

4 Buy

2 Hold

1 Sell

Moderate Buy

Genmab A/S

kr1779.24

kr111.05B

126.08

52.27%

4 Buy

2 Hold

1 Sell

Moderate Buy

GlaxoSmithKline

2167.00 p

£86.59B

12.93

71.44%

3 Buy

6 Hold

3 Sell

Hold

AstraZeneca

15276.00 p

£236.91B

28.13

58.02%

13 Buy

2 Hold

1 Sell

Strong Buy

Hikma Pharmaceuticals

1554.00 p

£2.87B

11.21

-25.23%

2 Buy

0 Hold

1 Sell

Moderate Buy

xxxxxxxxxxxxx

GE9 vs HIK

xxxxxxxxxxxxx

Performance Comparison

DE:GE9

Genmab A/S

242.60

79.20

48.47%

GB:0MGB

Genmab A/S

1,779.24

562.23

46.20%

GB:GSK

GlaxoSmithKline

2,167.00

941.78

76.87%

GB:AZN

AstraZeneca

15,276.00

5,429.61

55.14%

GB:HIK

Hikma Pharmaceuticals

1,326.50

-434.86

-24.69%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >